These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9851224)

  • 1. [Light chain deposition disease].
    Kanoh T
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):585-7. PubMed ID: 9851224
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrotoxic potential of Bence Jones proteins.
    Solomon A; Weiss DT; Kattine AA
    N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward understanding the molecular pathogenesis of monoclonal immunoglobulin light-chain deposition.
    Bellotti V; Merlini G
    Nephrol Dial Transplant; 1996 Sep; 11(9):1708-11. PubMed ID: 8918605
    [No Abstract]   [Full Text] [Related]  

  • 4. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
    Harris DL; King E; Ramsland PA; Edmundson AB
    J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloidosis associated with plasma cell dyscrasia.
    Isobe T
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1404-9. PubMed ID: 3150199
    [No Abstract]   [Full Text] [Related]  

  • 6. The kidney in plasma cell dyscrasias: Bence-Jones cast nephropathy and light chain deposit disease.
    Cohen AH
    Am J Kidney Dis; 1998 Sep; 32(3):529-32. PubMed ID: 9740176
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal complications of B-cell dyscrasias.
    Gallo G
    N Engl J Med; 1991 Jun; 324(26):1889-90. PubMed ID: 1904135
    [No Abstract]   [Full Text] [Related]  

  • 8. [M-component of serum formed by lambda-type Bence-Jones protein].
    Snigurowicz J; Rostkowska J; Powiertowska-Rezmer M
    Acta Haematol Pol; 1976; 7(2):103-9. PubMed ID: 820159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary light chain deposition disease: report of five cases and review of the literature.
    Bhargava P; Rushin JM; Rusnock EJ; Hefter LG; Franks TJ; Sabnis SG; Travis WD
    Am J Surg Pathol; 2007 Feb; 31(2):267-76. PubMed ID: 17255772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary diseases and non-amyloid light chain deposition].
    Colombat M; Stern M
    Rev Mal Respir; 2013 Sep; 30(7):524-6. PubMed ID: 24034455
    [No Abstract]   [Full Text] [Related]  

  • 11. Current concepts of the formation and composition of amyloid.
    Glenner GG
    Ann Clin Lab Sci; 1975; 5(4):257-63. PubMed ID: 808999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of immunoglobulin light chains in the pathogenesis of amyloid polyneuropathy associated with occult plasma-cell dyscrasia.
    Dalakas MC; Engel WK
    Trans Am Neurol Assoc; 1979; 104():227-9. PubMed ID: 233329
    [No Abstract]   [Full Text] [Related]  

  • 13. The action of collagenase on K-type Bence-Jones proteins.
    Vallet B; Tonnelle C; Coletti-Previero MA
    Pathol Biol (Paris); 1977 Jun; 25(6):369-73. PubMed ID: 199879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charge differences between in vivo deposits in immunoglobulin light chain amyloidosis and non-amyloid light chain deposition disease.
    Kaplan B; Livneh A; Gallo G
    Br J Haematol; 2007 Mar; 136(5):723-8. PubMed ID: 17223908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma.
    Iványi B
    Arch Pathol Lab Med; 1990 Sep; 114(9):986-7. PubMed ID: 2117910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and aggregation analysis of Bence Jones proteins from different light chain diseases.
    Sikkink LA; Ramirez-Alvarado M
    Amyloid; 2008 Mar; 15(1):29-39. PubMed ID: 18266119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin allotypes are not involved in systemic amyloidosis.
    Ockhuizen T; Westra H; Bijzet J; Post J; van Leeuwen M; van Rijswijk M
    J Rheumatol; 1985 Aug; 12(4):742-6. PubMed ID: 3932652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discovery of the immunoglobulin origin of amyloid fibrils and its pathogenetic significance.
    Glenner GG
    Acta Pathol Microbiol Scand Suppl; 1972; 233():114-21. PubMed ID: 5074621
    [No Abstract]   [Full Text] [Related]  

  • 19. Protein deposition diseases: when structurally altered proteins assemble out of place. With special emphasis on monoclonal immunoglobulin deposition disease causing erosive polyarthropathy.
    Husby G; Brandtzaeg P; Mellbye OJ; Thompson K; Sletten K; Aarset H
    Scand J Rheumatol; 2002; 31(2):60-5. PubMed ID: 12109648
    [No Abstract]   [Full Text] [Related]  

  • 20. Recurrent light and heavy chain deposition disease after renal transplantation.
    Alchi B; Nishi S; Iguchi S; Shimotori M; Sakatsume M; Ueno M; Narita I; Saito K; Takahashi K; Gejyo F
    Nephrol Dial Transplant; 2005 Jul; 20(7):1487-91. PubMed ID: 15840680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.